Search
Home
Join Today!
Renew!
Events
Username
Password
Keep me logged in
Home
About
About IPhA
Bylaws
Regions
Committees
Policy Manual
Driving Directions
Disclaimer
Privacy Statement
Membership
IPhA Member Spotlight
Join IPhA Today!
Renew YOUR Voice!
Types of Membership
10 Reasons to Join IPhA
Member Benefits
Printable Membership Application
Professional Development
Illinois Pharmacists Annual Conference
IPhA 2018 Annual Conference
IPhA 2019 Annual Conference
Certificate Training Programs
Webinars and CPE Programs
Illinois Pharmacy Legislative Day
Continuing Professional Development
Communications
Illinois Pharmacist
E-Info Exchange
PharmPhlash
Advertising
Advocacy
Illinois PharmTalk
Advocacy Resources
Legislative Tracking
Find Your Legislator
Pharmacy Advocacy Fund
Contacts
IPhA Board of Directors
IPhA House of Delegates
IPhA Committees
IPhA Foundation
IL Pharmacists Network
Illinois Pharmacy PAC
Local Associations
IPhA Staff
News
Forum
Career Center
Our Tweets
Tweets by @ILPharmacists
Our Sponsors
Our Sponsors
FDA - Medwatch Safety Alerts
MedWatch Safety Alert RSS Feed
Xeljanz, Xeljanz XR (tofacitinib): Safety Communication - Safety Trial Finds Increased Risk of Blood Clots in the Lungs and Death with Higher Dose in Rheumatoid Arthritis Patients
Fluoroquinolone Antibiotics: Safety Communication - Increased Risk of Ruptures or Tears in the Aorta Blood Vessel in Certain Patients
Gilenya (fingolimod): Drug Safety Communication - Severe Worsening of Multiple Sclerosis After Stopping the Medicine
Implanted Pumps: Safety Communication - Use Caution When Selecting Pain Medicine for Intrathecal Administration
powered by MemberClicks
